| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AORT | Common Stock | Options Exercise | $671,222 | +65,549 | +13% | $10.24 | 562,184 | 14 Feb 2023 | Direct | F1 |
| transaction | AORT | Common Stock | Sale | $747,207 | -56,500 | -10% | $13.22 | 505,684 | 14 Feb 2023 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AORT | Stock Options (Right to buy) | Options Exercise | $671,222 | -65,549 | -100% | $10.24 | 0 | 14 Feb 2023 | Commn Stock | 65,549 | $10.24 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 14, 2022 |
| F2 | Reflects the price of $ 13.224856 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price |
| F3 | Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2017. |